Literature DB >> 22391212

Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study.

Michael S Pedersen1, Michael E Benros, Esben Agerbo, Anders D Børglum, Preben B Mortensen.   

Abstract

OBJECTIVE: Autoimmune diseases and infections have been associated with an increased risk of schizophrenia that could be rooted in inflammatory mechanisms. However, other diseases characterized by a heightened immune response, such as atopic disorders, remain to be thoroughly investigated. The aim of this study was to investigate whether atopic disorders in the individual or in a first-degree relative affect the risk of developing schizophrenia.
METHOD: We linked two nationwide population-based registers: the Danish Psychiatric Central Register and the National Hospital Register. Two longitudinal designs were used: a cohort study and a case/sibling study. Rate ratios (RRs) and accompanying 95% confidence intervals (CIs) were obtained.
RESULTS: Hospital contact with any atopic disorder increased the RR of schizophrenia by 1.45 (95% CI=1.31-1.90). The increased risk was mainly driven by asthma: 1.59 (95% CI=1.31-1.90); this was confirmed when cases were compared with siblings instead of the background population. Hospital contact with other included atopic disorders (atopic dermatitis, urticaria and allergic rhinitis) increased the risk of schizophrenia significantly only if they were combined into one group. Hospital contact with asthma in a first-degree relative did not significantly increase the risk of schizophrenia.
CONCLUSION: This study indicates the existence of an association between atopic disorders in general and asthma in particular and the risk of developing schizophrenia. The study adds to a growing body of literature suggesting the possible involvement of immune processes in the pathophysiology of schizophrenia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22391212     DOI: 10.1016/j.schres.2012.02.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

1.  Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals.

Authors:  Holger J Sørensen; Philip R Nielsen; Michael E Benros; Carsten B Pedersen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2014-07-25       Impact factor: 9.306

Review 2.  Is there a role for immune-to-brain communication in schizophrenia?

Authors:  Golam M Khandaker; Robert Dantzer
Journal:  Psychopharmacology (Berl)       Date:  2015-06-04       Impact factor: 4.530

Review 3.  Psychosocial factors and behavioral medicine interventions in asthma.

Authors:  Thomas Ritz; Alicia E Meuret; Ana F Trueba; Anja Fritzsche; Andreas von Leupoldt
Journal:  J Consult Clin Psychol       Date:  2012-10-01

4.  Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.

Authors:  Ruyue Zhang; Arvid Sjölander; Alexander Ploner; Donghao Lu; Cynthia M Bulik; Sarah E Bergen
Journal:  Mol Psychiatry       Date:  2021-11-19       Impact factor: 13.437

5.  Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey.

Authors:  Carmen Moreno; Roberto Nuevo; Somnath Chatterji; Emese Verdes; Celso Arango; José Luis Ayuso-Mateos
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

Review 6.  Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.

Authors:  David Baumeister; Alice Russell; Carmine M Pariante; Valeria Mondelli
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

7.  Diagnostic progression to schizophrenia in 35,255 patients with obsessive-compulsive disorder: a longitudinal follow-up study.

Authors:  Mu-Hong Chen; Shih-Jen Tsai; Chih-Sung Liang; Chih-Ming Cheng; Tung-Ping Su; Tzeng-Ji Chen; Ya-Mei Bai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-24       Impact factor: 5.270

8.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.

Authors:  C J Carter
Journal:  J Pathog       Date:  2013-03-04

9.  [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.]

Authors:  A Fernandez; M Pasquet-Levy; G Laure; S Thümmler; F Askenazy
Journal:  Can J Psychiatry       Date:  2021-02-10       Impact factor: 5.321

Review 10.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.